Literature DB >> 33078723

Saudi Association for the Study of Liver diseases and Transplantation practice guidelines on the diagnosis and management of hepatocellular carcinoma.

Saleh A Alqahtani1, Faisal M Sanai2, Ashwaq Alolayan3, Faisal Abaalkhail4, Hamad Alsuhaibani5, Mazen Hassanain6, Waleed Alhazzani7, Abdullah Alsuhaibani5, Abdullah Algarni8, Alejandro Forner9, Richard S Finn10, Waleed K Al-Hamoudi11.   

Abstract

Entities:  

Keywords:  Hepatocellular carcinoma; SASLT; Saudi Arabia; liver cancer; practice guidelines

Year:  2020        PMID： 33078723      PMCID： PMC7768980          DOI： 10.4103/sjg.SJG_477_20

Source DB:  PubMed          Journal:  Saudi J Gastroenterol        ISSN： 1319-3767            Impact factor:   2.485


× No keyword cloud information.
  282 in total

1.  Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma.

Authors:  Jens Ricke; Heinz Josef Klümpen; Holger Amthauer; Irene Bargellini; Peter Bartenstein; Enrico N de Toni; Antonio Gasbarrini; Maciej Pech; Markus Peck-Radosavljevic; Peter Popovič; Olivier Rosmorduc; Eckart Schott; Max Seidensticker; Chris Verslype; Bruno Sangro; Peter Malfertheiner
Journal:  J Hepatol       Date:  2019-08-14       Impact factor: 25.083

2.  Transarterial chemoembolization combination therapy vs monotherapy in unresectable hepatocellular carcinoma: a meta-analysis.

Authors:  Lei Li; Jiangke Tian; Peng Liu; Xuan Wang; Zhenyu Zhu
Journal:  Tumori       Date:  2016-03-22       Impact factor: 2.098

3.  Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.

Authors:  J M Llovet; J Fuster; J Bruix
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

4.  Liver transplantation for hepatocellular carcinoma within the Milan criteria versus the University of California San Francisco criteria: a comparative study.

Authors:  Mohamed R Abdelfattah; Hussein Elsiesy; Hadeel Al-Manea; Dieter C Broering
Journal:  Eur J Gastroenterol Hepatol       Date:  2018-04       Impact factor: 2.566

5.  Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.

Authors:  Daniel R Wahl; Matthew H Stenmark; Yebin Tao; Erqi L Pollom; Elaine M Caoili; Theodore S Lawrence; Matthew J Schipper; Mary Feng
Journal:  J Clin Oncol       Date:  2015-11-30       Impact factor: 44.544

6.  Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines.

Authors:  Kenichi Takayasu; Shigeki Arii; Masatoshi Kudo; Takafumi Ichida; Osamu Matsui; Namiki Izumi; Yutaka Matsuyama; Michiie Sakamoto; Osamu Nakashima; Yonson Ku; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  J Hepatol       Date:  2011-12-13       Impact factor: 25.083

7.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

Review 8.  Hepatocellular carcinoma: surgical perspectives beyond the barcelona clinic liver cancer recommendations.

Authors:  Alfredo Guglielmi; Andrea Ruzzenente; Simone Conci; Alessandro Valdegamberi; Marco Vitali; Francesca Bertuzzo; Michela De Angelis; Guido Mantovani; Calogero Iacono
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

9.  Epidemiology, disease burden, and treatment strategies of chronic hepatitis C virus infections in Saudi Arabia in the new treatment paradigm shift.

Authors:  Abdulrahman A Aljumah; Faisal Abaalkhail; Hamad Al-Ashgar; Abdullah Assiri; Mohamed Babatin; Faleh Al Faleh; Abdullah Alghamdi; Raafat Al-Hakeem; Almoataz Hashim; Adel Alqutub; Homie Razavi; Faisal M Sanai; Khalid Al-Swat; Jonathan Schmelzer; Ibrahim Altraif
Journal:  Saudi J Gastroenterol       Date:  2016 Jul-Aug       Impact factor: 2.485

10.  Studying the Impact of Golgi Protein 73 Serving as a Candidate Biomarker in Early Diagnosis for Hepatocellular Carcinomazzm321990among Saudi Patients

Authors:  Randa Mohamed Ahmed Farag; Dujana Al Ayobi; Khalid A Alsaleh; Hye-Joo Kwon; Afaf EL-Ansary; Emad Anwar Dawoud
Journal:  Asian Pac J Cancer Prev       Date:  2019-01-25
View more
  4 in total

1.  Saudi association for the study of liver diseases and transplantation position statement on the hepatology workforce in Saudi Arabia.

Authors:  Bandar Al-Judaibi; M Katherine Dokus; Waleed Al-Hamoudi; Dieter Broering; Mohammad Mawardi; Nasser AlMasri; Mohammed Aljawad; Ibrahim H Altraif; Faisal Abaalkhail; Saleh A Alqahtani
Journal:  Saudi J Gastroenterol       Date:  2022 Mar-Apr       Impact factor: 2.485

Review 2.  Clinical application of advances and innovation in radiation treatment of hepatocellular carcinoma.

Authors:  Valerie J W Tong; Vishal G Shelat; Yew Kuo Chao
Journal:  J Clin Transl Res       Date:  2021-11-06

3.  The future health and economic burden of obesity-attributable type 2 diabetes and liver disease among the working-age population in Saudi Arabia.

Authors:  Timothy Coker; Jennifer Saxton; Lise Retat; Khalid Alswat; Suliman Alghnam; Rajaa Mohammad Al-Raddadi; Habeeb Ibrahim Abdul Razack; Laura Webber; Saleh A Alqahtani
Journal:  PLoS One       Date:  2022-07-14       Impact factor: 3.752

4.  An evaluation of the reporting quality in clinical practice guidelines for hepatocellular carcinoma using the RIGHT checklist.

Authors:  Haiyang Chen; Meng Tao; Ding Li; Jing Han; Cheng Cheng; Yanfang Ma; Yingxi Wu; Vishal G Shelat; Francisco Tustumi; Sanjaya K Satapathy; Koo Jeong Kang; Qiming Wang
Journal:  Ann Transl Med       Date:  2021-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.